Andy’s company is changing the way research gets done. Their technology will enable products to get researched sufficiently and safely so they can get to market and help people who need them most.
Salt Lake City, UT (PRWEB) October 17, 2011
Blackrock NeuroMed is pleased to announce that Andy Gotshalk, CEO, will present Advances in Neurosensing Technology at the Neurotech Leaders Forum to be held October 17-18, 2011 in San Francisco. Blackrock NeuroMed offers the neurotechnology industry the first high-definition EEG (electroencephalogram) brain activity recording and monitoring system for human neurological clinical applications. The flagship product, ‘Cervello Elite’ is the first system on the market that offers simultaneous EEG recording and single unit recording, with an easy to use software interface.
The Neurotech Leaders Forum is ‘the’ management and investment conference for neurotech professionals. The two-day conference offers an exclusive forum for neurotechnoloy executives and entrepreneurs to interact with investors, technologists and potential partners who are actively working to grow this new and exciting industry.
Gotshalk is CEO of BlackRock NeuroMed. He has more than fifteen years of experience in commercializing medical devices. Most recently Andrew successfully commercialized research products in the neurophysiology sector (Blackrock Microsystems) increasing revenue from $700k to +$11 million in less than four years. Prior to that Andrew was responsible for sales and operations for the Surgical Division of Haemonetics Corporation. Andrew has a Bachelor of Science in Mechanical Engineering from the Georgia Institute of Technology.
Gotshalk will be speaking during the Consumer session on Tuesday, October 18. He will look at new technologies impacting the neurosensing industry, including new sensors, software, and imaging systems. He will also examine how current EEG products are limited by the amount of data provided. He will describe his option for higher resolution data and additional data streams that cover the need for improved levels of diagnosis and treatment capabilities for neurological disorders.
Neurotech Leaders Forum founder, James Cavuoto, enthusiastically recommends attending the session. “Andy’s company is changing the way research gets done. Their technology will enable products to get researched sufficiently and safely so they can get to market and help people who need them most.”
About Neurotech Leaders Forum
Debuted in 2001, Neurotech Leaders Forum covers a range of technologies and market segments in the neuro space, including neuromodulation, neural prosthetics, neurosensing, and neurorehabilitation. The 2011 keynote will be will delivered by Kip Ludwig, director for plasticity and repair at the NIH/NINDS. This year features a first-ever Consumer Neurotech Conference on October 18. The full-day meeting will include sessions on neuromarketing, gaming, training, and cognitive enhancement applications of neurotechnology. For more information on the 2011 Neurotech Leaders Forum, call: 415 546 1259.
About Blackrock NeuroMed
Launched in 2011, Blackrock NeuroMed delivers a sophisticated EEG and single cell recording system to clinicians worldwide. Their turn-key solutions facilitate the study and utilization of electrical signals acquired from the brain and peripheral nervous system. The company was founded by Professor Florian Solzbacher, Director of Utah Nanofabrication Laboratory and co-Director of the Utah Nanotechnology Institute. The company provides enabling tools for the neuroscience, neural engineering and neuroprosthetics research and clinical community worldwide.